Table 3.
Males OR (95% CI) | Females OR (95% CI) | Overall OR (95% CI) | |
---|---|---|---|
Diabetes duration | 1.069 (1.011–1.167)a | 1.022 (0.975–1.071) | 1.044 (1.005–1.085)a |
Baseline BMI | 1.069 (0.988–1.157) | 0.986 (0.934–1.041) | 1.020 (0.977–1.065) |
Baseline HbA1c | 0.970 (0.673–1.398) | 0.667 (0.458–0.971)a | 0.809 (0.627–1.044) |
Therapy* | 0.735 (0.281–1.921) | 0.656 (0.321–1.341) | 0.758 (0.437–1.314) |
Notes: Results are expressed as the 1-year percent loss value from the baseline weight ≥ 75th percentile (≥8.5%). In addition, the results are also expressed as OR (95% CI) after a logistics regression model where the dependent variable was target outcome “y” (yes = 1; no = 0); age, duration of diabetes, baseline HbA1c, background antidiabetic therapy, and baseline BMI were the independent variables.
Therapy was categorized as metformin = 0; sulphonylureas or associations = 1.
statistically significant.
Abbreviations: OR, odds ratio; CI, confidence interval; BMI, body mass index; HbA1c, hemoglobin A1c.